| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 9/16/2021 | TBPH Theravance Biopharma | Lower Price Target | $7.00 | $29.00 ➝ $10.00 | Outperform | Low |
| 9/14/2021 | QURE uniQure | Reiterated Rating | $37.00 | | Buy | Medium |
| 9/14/2021 | PFE Pfizer | Reiterated Rating | $44.00 | $49.00 | Hold | Low |
| 9/14/2021 | BMRN BioMarin Pharmaceutical | Reiterated Rating | $77.00 | | Buy | Low |
| 9/13/2021 | ADAP Adaptimmune Therapeutics | Boost Price Target | $5.00 | $6.00 ➝ $7.00 | Market Perform | High |
| 9/13/2021 | MIRM Mirum Pharmaceuticals | Lower Price Target | $18.00 | $33.00 ➝ $32.00 | Outperform | High |
| 9/12/2021 | GMTX Gemini Therapeutics | Reiterated Rating | $5.00 | | Buy | Medium |
| 9/12/2021 | KALV KalVista Pharmaceuticals | Reiterated Rating | $19.00 | $51.00 | Buy | Low |
| 9/12/2021 | MRNA Moderna | Reiterated Rating | $438.00 | | Sell | High |
| 9/10/2021 | CLDX Celldex Therapeutics | Initiated Coverage | $53.00 | $68.00 | Outperform | High |
| 9/9/2021 | CFRX ContraFect | Initiated Coverage | $4.00 | $14.00 | Outperform | High |
| 9/9/2021 | AMRN Amarin | Initiated Coverage | $5.00 | $12.00 | Outperform | Low |
| 9/9/2021 | SCPH scPharmaceuticals | Initiated Coverage | $6.00 | $6.00 | Market Perform | High |
| 9/9/2021 | ALGS Aligos Therapeutics | Initiated Coverage | $16.00 | $29.00 | Outperform | Medium |
| 9/9/2021 | MYOV Myovant Sciences | Initiated Coverage | $22.00 | $24.00 | Market Perform | High |
| 9/9/2021 | AVIR Atea Pharmaceuticals | Initiated Coverage | $27.00 | $60.00 | Outperform | High |
| 9/9/2021 | NVTA Invitae | Reiterated Rating | $30.00 | | Buy | High |
| 9/9/2021 | ENTA Enanta Pharmaceuticals | Initiated Coverage | $58.00 | $55.00 | Market Perform | High |
| 9/9/2021 | HQY HealthEquity | Upgrade | $62.00 | $80.00 | Market Perform ➝ Outperform | High |
| 9/9/2021 | BRKR Bruker | Boost Price Target | $83.00 | $90.00 ➝ $100.00 | Outperform | Low |
| 9/7/2021 | ADAP Adaptimmune Therapeutics | Boost Price Target | $5.00 | $5.00 ➝ $6.00 | Market Perform | High |
| 9/7/2021 | ELYM Eliem Therapeutics | Initiated Coverage | $25.00 | $33.00 | Outperform | High |
| 9/5/2021 | BAX Baxter International | Reiterated Rating | $83.00 | | Buy | Low |
| 9/2/2021 | IPHA Innate Pharma | Upgrade | $6.00 | $7.00 | Market Perform ➝ Outperform | High |
| 9/2/2021 | ABBV AbbVie | Lower Price Target | $108.00 | $148.00 ➝ $142.00 | Outperform | Medium |
| 9/2/2021 | VEEV Veeva Systems | Boost Price Target | $302.00 | $294.00 ➝ $296.00 | Market Perform | High |
| 8/27/2021 | MOLN Molecular Partners | Lower Price Target | $20.00 | $36.00 ➝ $35.00 | Outperform | Low |
| 8/26/2021 | ASND Ascendis Pharma A/S | Boost Price Target | $157.00 | $178.00 ➝ $182.00 | Outperform | High |
| 8/26/2021 | ISRG Intuitive Surgical | Boost Price Target | $1,031.00 | $975.00 ➝ $1,040.00 | Market Perform | Medium |
| 8/25/2021 | PRTC PureTech Health | Boost Price Target | $50.00 | $74.00 ➝ $76.00 | Outperform | Medium |
| 8/24/2021 | RXST RxSight | Initiated Coverage | $13.00 | $20.00 | Outperform | High |
| 8/24/2021 | TBPH Theravance Biopharma | Lower Price Target | $7.00 | $37.00 ➝ $29.00 | Outperform | High |
| 8/23/2021 | REPL Replimune Group | Lower Price Target | $32.00 | $55.00 ➝ $49.00 | Outperform | High |
| 8/22/2021 | ALVR AlloVir | Initiated Coverage | $23.00 | | Buy | High |
| 8/20/2021 | ABBV AbbVie | Boost Price Target | $108.00 | $145.00 ➝ $148.00 | Outperform | Low |
| 8/19/2021 | MRNS Marinus Pharmaceuticals | Reiterated Rating | $11.00 | | Buy | High |
| 8/19/2021 | AMYT Amryt Pharma | Initiated Coverage | $12.00 | $22.00 | Outperform | Medium |
| 8/19/2021 | AUPH Aurinia Pharmaceuticals | Reiterated Rating | $19.00 | | Buy | Low |
| 8/19/2021 | RCKT Rocket Pharmaceuticals | Reiterated Rating | $34.00 | | Buy | High |
| 8/19/2021 | INOV Inovalon | Downgrade | $40.00 | $45.00 ➝ $41.00 | Outperform ➝ Market Perform | Low |
| 8/19/2021 | ALC Alcon | Boost Price Target | $86.00 | $71.00 ➝ $82.00 | Positive ➝ Market Perform | N/A |
| 8/19/2021 | ILMN Illumina | Downgrade | $450.00 | $425.00 | Outperform ➝ Market Perform | High |
| 8/18/2021 | PINC Premier | Boost Price Target | $40.00 | $44.00 ➝ $46.00 | Outperform | High |
| 8/18/2021 | A Agilent Technologies | Boost Price Target | $172.00 | $160.00 ➝ $170.00 | Outperform | Medium |
| 8/17/2021 | TALK Italk | Reiterated Rating | $5.00 | | Buy | Medium |
| 8/17/2021 | LVTX Lava Therapeutics B.V. | Lower Price Target | $6.00 | $26.00 ➝ $24.00 | Outperform | Low |
| 8/17/2021 | FSTX F-star Therapeutics | Lower Price Target | $7.00 | $39.00 ➝ $35.00 | Outperform | High |
| 8/17/2021 | TVTX Travere Therapeutics | Boost Price Target | $22.00 | $27.00 ➝ $37.00 | Outperform | High |
| 8/17/2021 | CRBU Caribou Biosciences | Initiated Coverage | $27.00 | $32.00 | Outperform | High |
| 8/16/2021 | BOLT Bolt Biotherapeutics | Boost Price Target | $15.00 | $34.00 ➝ $35.00 | Outperform | Low |
| 8/16/2021 | RXRX Recursion Pharmaceuticals | Lower Price Target | $24.00 | $33.00 ➝ $30.00 | Outperform | High |
| 8/16/2021 | SBTX Silverback Therapeutics | Boost Price Target | $12.00 | $46.00 ➝ $49.00 | Outperform | High |
| 8/15/2021 | CBAY CymaBay Therapeutics | Reiterated Rating | $4.00 | $10.00 | Buy | High |
| 8/15/2021 | VIRX Viracta Therapeutics | Reiterated Rating | $9.00 | $18.00 | Buy | High |
| 8/15/2021 | ABCL AbCellera Biologics | Reiterated Rating | $19.00 | | Buy | Low |
| 8/15/2021 | ETNB 89bio | Reiterated Rating | $19.00 | $62.00 | Buy | High |
| 8/15/2021 | NPCE NeuroPace | Reiterated Rating | $18.00 | $30.00 | Buy | Medium |
| 8/15/2021 | FULC Fulcrum Therapeutics | Reiterated Rating | $28.00 | $23.00 | Buy | Low |
| 8/15/2021 | IPSC Century Therapeutics | Reiterated Rating | $30.00 | | Buy | High |
| 8/15/2021 | GDRX GoodRx | Initiated Coverage | $46.00 | $56.00 | Buy | High |
| 8/13/2021 | FULC Fulcrum Therapeutics | Boost Price Target | $28.00 | $23.00 ➝ $37.00 | Outperform | Low |
| 8/13/2021 | ITOS iTeos Therapeutics | Lower Price Target | $28.00 | $56.00 ➝ $55.00 | Outperform | Medium |
| 8/13/2021 | BNTX BioNTech | Boost Price Target | $370.00 | $159.00 ➝ $293.00 | Market Perform | Low |
| 8/12/2021 | SIOX Sio Gene Therapies | Lower Price Target | $2.00 | $7.00 ➝ $6.00 | Outperform | Medium |
| 8/12/2021 | RVMD Revolution Medicines | Lower Price Target | $30.00 | $46.00 ➝ $38.00 | Outperform | High |
| 8/12/2021 | RAPT RAPT Therapeutics | Initiated Coverage | $38.00 | $49.00 | Outperform | High |
| 8/12/2021 | GMAB Genmab A/S | Boost Price Target | $42.00 | $37.00 ➝ $42.00 | Market Perform | Low |
| 8/11/2021 | XENT Intersect ENT | Downgrade | $27.00 | $28.25 | Outperform ➝ Market Perform | Low |
| 8/11/2021 | NARI Inari Medical | Lower Price Target | $81.00 | $126.00 ➝ $110.00 | Outperform | High |
| 8/10/2021 | ADAP Adaptimmune Therapeutics | Lower Price Target | $5.00 | $6.00 ➝ $5.00 | Market Perform | High |
| 8/10/2021 | GOSS Gossamer Bio | Lower Price Target | $10.00 | $19.00 ➝ $15.00 | Outperform | High |
| 8/10/2021 | FGEN FibroGen | Lower Price Target | $12.00 | $35.00 ➝ $30.00 | Positive ➝ Outperform | Low |
| 8/10/2021 | AXSM Axsome Therapeutics | Lower Price Target | $29.00 | $115.00 ➝ $75.00 | Positive ➝ Outperform | High |
| 8/10/2021 | RCKT Rocket Pharmaceuticals | Lower Price Target | $34.00 | $66.00 ➝ $62.00 | Outperform | Medium |
| 8/10/2021 | SWAV ShockWave Medical | Boost Price Target | $231.00 | $208.00 ➝ $220.00 | Outperform | High |
| 8/9/2021 | BLUE bluebird bio | Downgrade | $18.00 | $64.00 ➝ $20.00 | Outperform ➝ Market Perform | High |
| 8/9/2021 | REPL Replimune Group | Lower Price Target | $32.00 | $56.00 ➝ $55.00 | Outperform | Medium |
| 8/8/2021 | TALK Italk | Reiterated Rating | $5.00 | $11.00 | Buy | High |
| 8/8/2021 | ACIU AC Immune | Reiterated Rating | $7.00 | $17.00 | Buy | Low |
| 8/8/2021 | EOLS Evolus | Reiterated Rating | $8.00 | $18.00 | Buy | Medium |
| 8/8/2021 | ACRS Aclaris Therapeutics | Reiterated Rating | $17.00 | $26.00 | Buy | Medium |
| 8/8/2021 | MASS 908 Devices | Reiterated Rating | $37.00 | | Buy | Low |
| 8/6/2021 | ATNX Athenex | Lower Price Target | $3.00 | $5.00 ➝ $4.00 | Market Perform | High |
| 8/6/2021 | KPTI Karyopharm Therapeutics | Downgrade | $6.00 | $6.00 | Outperform ➝ Market Perform | High |
| 8/6/2021 | HARP Harpoon Therapeutics | Lower Price Target | $8.00 | $29.00 ➝ $25.00 | Outperform | High |
| 8/6/2021 | TCRR TCR2 Therapeutics | Lower Price Target | $16.00 | $34.00 ➝ $31.00 | Outperform | High |
| 8/6/2021 | RDUS Radius Health | Boost Price Target | $12.00 | $24.00 ➝ $26.00 | Market Perform | High |
| 8/6/2021 | MIRM Mirum Pharmaceuticals | Lower Price Target | $18.00 | $38.00 ➝ $33.00 | Outperform | High |
| 8/6/2021 | NKTR Nektar Therapeutics | Lower Price Target | $16.00 | $20.00 ➝ $19.00 | Market Perform | Low |
| 8/6/2021 | ZGNX Zogenix | Lower Price Target | $15.00 | $42.00 ➝ $37.00 | Outperform | High |
| 8/6/2021 | MDRX Allscripts Healthcare Solutions | Boost Price Target | $14.00 | $17.00 ➝ $19.00 | Market Perform | High |
| 8/6/2021 | KURA Kura Oncology | Boost Price Target | $20.00 | $40.00 ➝ $41.00 | Outperform | High |
| 8/6/2021 | RCUS Arcus Biosciences | Boost Price Target | $33.00 | $63.00 ➝ $68.00 | Outperform | High |
| 8/6/2021 | DRNA Dicerna Pharmaceuticals | Lower Price Target | $21.00 | $54.00 ➝ $47.00 | Outperform | High |
| 8/6/2021 | PGNY Progyny | Lower Price Target | $61.00 | $64.00 ➝ $59.00 | Outperform | High |
| 8/6/2021 | BBIO BridgeBio Pharma | Lower Price Target | $49.00 | $71.00 ➝ $66.00 | Outperform | Medium |
| 8/6/2021 | HCAT Health Catalyst | Boost Price Target | $55.00 | $62.00 ➝ $64.00 | Outperform | Medium |
| 8/6/2021 | BDX Becton, Dickinson and | Lower Price Target | $262.00 | $260.00 ➝ $250.00 | Market Perform | Medium |
| 8/6/2021 | PODD Insulet | Lower Price Target | $287.00 | $325.00 ➝ $300.00 | Outperform | High |
| 8/6/2021 | ABMD Abiomed | Boost Price Target | $357.00 | $335.00 ➝ $375.00 | Market Perform | Medium |
